Palomar (NASDAQ:PLMR) Releases Earnings Results, Beats Expectations By $0.18 EPS

Palomar (NASDAQ:PLMRGet Free Report) posted its quarterly earnings data on Wednesday. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.06 by $0.18, FiscalAI reports. Palomar had a return on equity of 21.93% and a net margin of 22.59%.The company had revenue of $492.63 million during the quarter, compared to analyst estimates of $204.58 million. During the same period in the previous year, the business earned $1.52 EPS. Palomar’s quarterly revenue was up 62.7% on a year-over-year basis.

Palomar Stock Down 7.6%

Palomar stock traded down $10.03 during trading on Thursday, reaching $121.61. The stock had a trading volume of 42,866 shares, compared to its average volume of 222,938. Palomar has a 52-week low of $107.75 and a 52-week high of $175.85. The business has a 50 day moving average price of $128.28 and a 200 day moving average price of $123.20. The stock has a market cap of $3.22 billion, a PE ratio of 18.97 and a beta of 0.44.

Insider Buying and Selling

In other Palomar news, insider Angela L. Grant sold 260 shares of the firm’s stock in a transaction dated Saturday, January 31st. The stock was sold at an average price of $121.75, for a total transaction of $31,655.00. Following the transaction, the insider owned 7,033 shares of the company’s stock, valued at approximately $856,267.75. This trade represents a 3.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO T Christopher Uchida sold 545 shares of the firm’s stock in a transaction that occurred on Saturday, January 31st. The stock was sold at an average price of $121.74, for a total value of $66,348.30. Following the transaction, the chief financial officer owned 14,005 shares in the company, valued at $1,704,968.70. This represents a 3.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 58,998 shares of company stock valued at $7,255,669 over the last 90 days. 3.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Palomar

Institutional investors have recently modified their holdings of the business. Royal Bank of Canada lifted its position in shares of Palomar by 49.1% during the first quarter. Royal Bank of Canada now owns 2,956 shares of the company’s stock worth $406,000 after purchasing an additional 974 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Palomar by 5.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,427 shares of the company’s stock worth $2,115,000 after purchasing an additional 791 shares during the last quarter. NewEdge Advisors LLC acquired a new stake in Palomar in the 1st quarter valued at approximately $66,000. United Services Automobile Association acquired a new position in Palomar during the 1st quarter worth $223,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Palomar by 11.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 72,661 shares of the company’s stock valued at $9,960,000 after buying an additional 7,754 shares in the last quarter. 90.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PLMR has been the subject of a number of analyst reports. JPMorgan Chase & Co. upped their price target on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Keefe, Bruyette & Woods raised their price objective on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 6th. Weiss Ratings upgraded shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. Wall Street Zen lowered Palomar from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Finally, Evercore ISI started coverage on Palomar in a research report on Monday. They set an “outperform” rating and a $150.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Palomar has a consensus rating of “Moderate Buy” and an average price target of $158.14.

Read Our Latest Stock Analysis on Palomar

Key Palomar News

Here are the key news stories impacting Palomar this week:

Palomar Company Profile

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Featured Stories

Earnings History for Palomar (NASDAQ:PLMR)

Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.